These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30597769)

  • 1. Langerhans cell histiocytosis in adults is associated with a high prevalence of hematologic and solid malignancies.
    Ma J; Laird JH; Chau KW; Chelius MR; Lok BH; Yahalom J
    Cancer Med; 2019 Jan; 8(1):58-66. PubMed ID: 30597769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes among adults with Langerhans cell histiocytosis.
    Goyal G; Acosta-Medina AA; Abeykoon JP; Dai C; Ravindran A; Vassallo R; Ryu JH; Shah MV; Bennani NN; Young JR; Bach CR; Ruan GJ; Zanwar S; Tobin WO; Koster MJ; Davidge-Pitts CJ; Gruber LM; Dasari S; Rech KL; Go RS
    Blood Adv; 2023 Nov; 7(21):6568-6578. PubMed ID: 37698994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Langerhans cell histiocytosis and associated malignancies: A retrospective analysis of 270 patients.
    Bagnasco F; Zimmermann SY; Egeler RM; Nanduri VR; Cammarata B; Donadieu J; Lehrnbecher T; Haupt R
    Eur J Cancer; 2022 Sep; 172():138-145. PubMed ID: 35772351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Langerhans cell histiocytosis first presenting in the skin in adults: frequent association with a second haematological malignancy.
    Edelbroek JR; Vermeer MH; Jansen PM; Stoof TJ; van der Linden MM; Horváth B; van Baarlen J; Willemze R
    Br J Dermatol; 2012 Dec; 167(6):1287-94. PubMed ID: 22835048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, prevalence and survival in patients with Langerhans cell histiocytosis: A national registry study from England, 2013-2019.
    Liu H; Stiller CA; Crooks CJ; Rous B; Bythell M; Broggio J; Rankin J; Nanduri V; Lanyon P; Card TR; Ban L; Elliss-Brookes L; Broughan JM; Paley L; Wong K; Bacon A; Bishton M; West J
    Br J Haematol; 2022 Dec; 199(5):728-738. PubMed ID: 36122574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute leukemia in association with Langerhans cell histiocytosis.
    Egeler RM; Neglia JP; Aricò M; Favara BE; Heitger A; Nesbit ME
    Med Pediatr Oncol; 1994; 23(2):81-5. PubMed ID: 8202046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Langerhans cell histiocytosis of the temporal bone: A review of 29 cases at a single center.
    Modest MC; Garcia JJ; Arndt CS; Carlson ML
    Laryngoscope; 2016 Aug; 126(8):1899-904. PubMed ID: 26535795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late outcomes in children with Langerhans cell histiocytosis.
    Chow TW; Leung WK; Cheng FWT; Kumta SM; Chu WCW; Lee V; Shing MMK; Li CK
    Arch Dis Child; 2017 Sep; 102(9):830-835. PubMed ID: 28442470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000-2004.
    Guyot-Goubin A; Donadieu J; Barkaoui M; Bellec S; Thomas C; Clavel J
    Pediatr Blood Cancer; 2008 Jul; 51(1):71-5. PubMed ID: 18260117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of Langerhans cell histiocytosis in children: a population-based study.
    Stålemark H; Laurencikas E; Karis J; Gavhed D; Fadeel B; Henter JI
    Pediatr Blood Cancer; 2008 Jul; 51(1):76-81. PubMed ID: 18266220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study.
    Tazi A; Lorillon G; Haroche J; Neel A; Dominique S; Aouba A; Bouaziz JD; de Margerie-Melon C; Bugnet E; Cottin V; Comont T; Lavigne C; Kahn JE; Donadieu J; Chevret S
    Orphanet J Rare Dis; 2017 May; 12(1):95. PubMed ID: 28532436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of second primary malignancies and cause-specific mortality in pediatric and adult langerhans cell histiocytosis.
    Goyal G; Parikh R; Richman J; Abeykoon JP; Morlote D; Go RS; Bhatia S
    Leuk Res; 2023 Mar; 126():107032. PubMed ID: 36758375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relation of Langerhans cell histiocytosis to acute leukemia, lymphomas, and other solid tumors. The LCH-Malignancy Study Group of the Histiocyte Society.
    Egeler RM; Neglia JP; Aricò M; Favara BE; Heitger A; Nesbit ME; Nicholson HS
    Hematol Oncol Clin North Am; 1998 Apr; 12(2):369-78. PubMed ID: 9561906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The annual incidence of Langerhans cell histiocytosis among adults living in Greece.
    Makras P; Stathi D; Yavropoulou M; Tsoli M; Kaltsas G
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28422. PubMed ID: 32618036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Langerhans cell histiocytosis of skull: a retrospective study of 18 cases.
    Zhang XH; Zhang J; Chen ZH; Sai K; Chen YS; Wang J; Ke C; Guo CC; Chen ZP; Mou YG
    Ann Palliat Med; 2017 Apr; 6(2):159-164. PubMed ID: 28061539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group.
    Haupt R; Nanduri V; Calevo MG; Bernstrand C; Braier JL; Broadbent V; Rey G; McClain KL; Janka-Schaub G; Egeler RM
    Pediatr Blood Cancer; 2004 May; 42(5):438-44. PubMed ID: 15049016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The international dataset on the association between Langerhans Cell Histiocytosis and other malignancies.
    Bagnasco F; Zimmermann SY; Egeler RM; Nanduri VR; Cammarata B; Donadieu J; Lehrnbecher T; Haupt R
    Data Brief; 2022 Dec; 45():108604. PubMed ID: 36188132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study.
    Héritier S; Barkaoui MA; Miron J; Thomas C; Moshous D; Lambilliotte A; Mazingue F; Kebaili K; Jeziorski E; Plat G; Aladjidi N; Pacquement H; Galambrun C; Brugières L; Leverger G; Mansuy L; Paillard C; Deville A; Pagnier A; Lutun A; Gillibert-Yvert M; Stephan JL; Cohen-Aubart F; Haroche J; Pellier I; Millot F; Gandemer V; Martin-Duverneuil N; Taly V; Hélias-Rodzewicz Z; Emile JF; Hoang-Xuan K; Idbaih A; Donadieu J
    Br J Haematol; 2018 Nov; 183(4):608-617. PubMed ID: 30421536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Langerhans Cell Histiocytosis Associated With Underlying Hematolymphoid Disorders in Adults: Report of 2 Cases and Review of the Literature.
    Kiavash K; Malone JC
    Am J Dermatopathol; 2018 Aug; 40(8):588-593. PubMed ID: 30035752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Langerhans cell histiocytosis of the head and neck in the pediatric population in a tertiary center: Clinical presentation, classification and treatment.
    García Díaz MP; De Luca Sologaistoa A; De Paula Vernetta C; Moreno MA; Galeano Paniagua LA; Fernández MM; Carceller MA
    Int J Pediatr Otorhinolaryngol; 2022 Apr; 155():111073. PubMed ID: 35220158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.